Translational gene expression control in Chlamydia trachomatis

Area of Science:

• Microbiology
• Molecular Biology
• Bacterial Pathogenesis

Background:

• Chlamydia trachomatis exhibits a complex developmental cycle crucial for pathogenesis.
• Limited genetic tools have historically hindered the study of Chlamydia's regulatory mechanisms.
• Understanding gene regulation is key to deciphering Chlamydia's pathogenesis.

Purpose of the Study:

• To develop a novel translational control system for regulating gene expression in Chlamydia.
• To overcome limitations in existing genetic tools for studying Chlamydia trachomatis.
• To enable independent control of gene expression timing and strength.

Main Methods:

• Development of a synthetic riboswitch (riboswitch E) inducible with theophylline.
• Integration of the riboswitch with various promoters (T5-lac, pgp4, anhydrotetracycline-responsive) in C. trachomatis.
• Combination of Tet transcriptional inducible promoter with riboswitch translational control.

Main Results:

• The synthetic riboswitch effectively inhibited translation and allowed for theophylline-induced protein expression across different promoters.
• Combining Tet promoter with riboswitch achieved strong repression and enabled expression of the regulatory protein HctB.
• Demonstrated independent control of gene expression timing and strength.

Conclusions:

• A synthetic riboswitch system provides a powerful new tool for Chlamydia gene expression studies.
• This system allows for precise, independent regulation of gene expression, aiding research into virulence and regulatory genes.
• The developed tool significantly advances the study of Chlamydia trachomatis pathogenesis.